XTANT MEDICAL HOLDINGS, INC. (XTNT) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
43/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseXTNT / S&P -25.00% / 15.20% |
LoseXTNT / S&P -14.27% / 15.00% |
WinXTNT / S&P 100.00% / 50.40% |
| 2026-Q10/3 |
LoseXTNT / S&P -28.21% / -4.33% |
LoseXTNT / S&P -0.32% / 11.30% |
LoseXTNT / S&P -111.11% / 27.70% |
| 2025-Q42/3 |
WinXTNT / S&P 20.00% / 2.65% |
WinXTNT / S&P 14.21% / 9.00% |
LoseXTNT / S&P -125.00% / 13.40% |
| 2025-Q31/3 |
LoseXTNT / S&P -12.16% / 8.12% |
WinXTNT / S&P 16.88% / 4.61% |
LoseXTNT / S&P -107.69% / 13.45% |
| 2025-Q23/3 |
WinXTNT / S&P 57.45% / 10.94% |
WinXTNT / S&P 15.16% / 4.83% |
WinXTNT / S&P 100.00% / 10.63% |
| 2025-Q13/3 |
WinXTNT / S&P 6.82% / -4.27% |
WinXTNT / S&P 20.81% / 4.98% |
WinXTNT / S&P 800.00% / 10.57% |
| 2024-Q41/3 |
LoseXTNT / S&P -35.29% / 2.41% |
WinXTNT / S&P 28.44% / 5.25% |
LoseXTNT / S&P -1729382256910270464.00% / 6.15% |
| 2024-Q32/3 |
WinXTNT / S&P 7.94% / 5.89% |
WinXTNT / S&P 45.11% / 5.89% |
LoseXTNT / S&P -1400.00% / 6.11% |
| 2024-Q21/3 |
LoseXTNT / S&P -46.15% / 4.28% |
WinXTNT / S&P 63.37% / 5.38% |
LoseXTNT / S&P -77.78% / 5.12% |
| 2024-Q11/3 |
LoseXTNT / S&P 3.54% / 10.56% |
WinXTNT / S&P 60.81% / 5.71% |
LoseXTNT / S&P -88.89% / 5.59% |
| 2023-Q41/3 |
LoseXTNT / S&P 2.73% / 11.69% |
WinXTNT / S&P 57.50% / 6.81% |
LoseXTNT / S&P -100.00% / 7.78% |
| 2023-Q32/3 |
WinXTNT / S&P 18.28% / -3.27% |
WinXTNT / S&P 38.46% / 7.52% |
LoseXTNT / S&P -109.09% / -5.03% |
| 2023-Q22/3 |
WinXTNT / S&P 45.31% / 8.74% |
WinXTNT / S&P 21.30% / 9.50% |
LoseXTNT / S&P -10.00% / -8.57% |
| 2023-Q12/3 |
LoseXTNT / S&P -3.03% / 7.50% |
WinXTNT / S&P 13.06% / 10.77% |
WinXTNT / S&P 0.00% / -15.69% |
| 2022-Q41/3 |
LoseXTNT / S&P -8.33% / 7.56% |
LoseXTNT / S&P 4.89% / 11.88% |
WinXTNT / S&P 66.67% / -17.99% |
| 2022-Q31/3 |
WinXTNT / S&P 38.46% / -4.88% |
LoseXTNT / S&P 2.46% / 13.47% |
LoseXTNT / S&P -155.00% / -1.41% |
| 2022-Q20/3 |
LoseXTNT / S&P -23.53% / -16.10% |
LoseXTNT / S&P 0.78% / 13.71% |
LoseXTNT / S&P -183.33% / 11.04% |
| 2022-Q12/3 |
WinXTNT / S&P 21.43% / -4.60% |
LoseXTNT / S&P 8.96% / 15.97% |
WinXTNT / S&P 50.00% / 42.23% |
| 2021-Q40/3 |
LoseXTNT / S&P -49.55% / 11.03% |
LoseXTNT / S&P 3.61% / 15.00% |
LoseXTNT / S&P -76.00% / 96.40% |
| 2021-Q30/3 |
LoseXTNT / S&P -31.90% / 0.58% |
LoseXTNT / S&P -1.74% / 10.77% |
LoseXTNT / S&P -132.79% / 69.42% |
| 2021-Q20/3 |
LoseXTNT / S&P -30.93% / 8.55% |
LoseXTNT / S&P -4.21% / 6.58% |
LoseXTNT / S&P -118.46% / 51.81% |
| 2021-Q11/3 |
WinXTNT / S&P 96.67% / 6.17% |
LoseXTNT / S&P -18.54% / -1.06% |
LoseXTNT / S&P -90.16% / 7.39% |
| 2020-Q41/3 |
WinXTNT / S&P 46.34% / 12.15% |
LoseXTNT / S&P -17.54% / -3.72% |
LoseXTNT / S&P -60.32% / -33.42% |
| 2020-Q30/3 |
LoseXTNT / S&P -8.89% / 8.93% |
LoseXTNT / S&P -14.69% / -2.04% |
LoseXTNT / S&P -88.45% / -27.10% |
| 2020-Q21/3 |
WinXTNT / S&P 34.33% / 20.54% |
LoseXTNT / S&P -14.12% / -0.46% |
LoseXTNT / S&P -87.92% / -27.11% |
| 2020-Q10/3 |
LoseXTNT / S&P -58.13% / -19.60% |
LoseXTNT / S&P -11.64% / 3.47% |
LoseXTNT / S&P -89.13% / -14.75% |
| 2019-Q40/3 |
LoseXTNT / S&P -43.66% / 9.07% |
LoseXTNT / S&P -10.29% / 5.36% |
LoseXTNT / S&P -89.67% / 2.99% |
| 2019-Q30/3 |
LoseXTNT / S&P -5.33% / 1.70% |
LoseXTNT / S&P -10.06% / 5.02% |
LoseXTNT / S&P -73.78% / 0.21% |
| 2019-Q20/3 |
LoseXTNT / S&P -1.64% / 4.30% |
LoseXTNT / S&P -10.82% / 6.64% |
LoseXTNT / S&P -78.92% / 8.65% |
| 2019-Q11/3 |
WinXTNT / S&P 89.44% / 13.65% |
LoseXTNT / S&P -9.38% / 8.12% |
LoseXTNT / S&P -82.23% / 14.29% |
| 2018-Q40/3 |
LoseXTNT / S&P -58.18% / -13.52% |
LoseXTNT / S&P -12.71% / 9.05% |
LoseXTNT / S&P -82.44% / 18.23% |
| 2018-Q30/3 |
LoseXTNT / S&P -30.63% / 7.71% |
LoseXTNT / S&P -16.20% / 10.21% |
LoseXTNT / S&P -39.23% / 19.06% |
| 2018-Q20/3 |
LoseXTNT / S&P -29.66% / 3.43% |
LoseXTNT / S&P -16.81% / 9.03% |
LoseXTNT / S&P -8.60% / 14.46% |
| 2018-Q12/3 |
WinXTNT / S&P 15.35% / -0.76% |
LoseXTNT / S&P -14.01% / 7.68% |
WinXTNT / S&P 44.42% / 12.46% |
| 2017-Q41/3 |
LoseXTNT / S&P -20.83% / 6.64% |
LoseXTNT / S&P -8.23% / 7.03% |
WinXTNT / S&P 88.19% / 13.82% |
| 2017-Q31/3 |
WinXTNT / S&P 9.09% / 4.48% |
LoseXTNT / S&P -0.28% / 5.68% |
LoseXTNT / S&P -15163.64% / 17.57% |
| 2017-Q23/3 |
WinXTNT / S&P 6.45% / 3.09% |
WinXTNT / S&P 10.47% / 4.83% |
WinXTNT / S&P 139500.00% / 17.74% |
| 2017-Q13/3 |
WinXTNT / S&P 12.73% / 6.07% |
WinXTNT / S&P 28.65% / 3.67% |
WinXTNT / S&P 36333.33% / 13.32% |
| 2016-Q42/3 |
LoseXTNT / S&P -51.33% / 3.82% |
WinXTNT / S&P 51.66% / 2.09% |
WinXTNT / S&P 8690.48% / 7.05% |
| 2016-Q31/3 |
LoseXTNT / S&P -40.84% / 3.85% |
WinXTNT / S&P 90.14% / 0.20% |
LoseXTNT / S&P -110.14% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | XTNT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -48.44% | 20.78% |
| Annualized return | -48.44% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | XTNT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -73.60% | 83.14% |
| Annualized return | -23.38% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | XTNT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.45% | 319.30% |
| Annualized return | -30.72% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |